News

Get to know what's happening behind the scenes.

Learn more

Featured

Blog

Read the latest on our blog. Let's Talk Innovation.

Social

Stay connected with us on social media.

twitter_logo_20px.jpg @JNJinnovation

Events

Pages

Press Releases

Read our latest news.

  • Johnson & Johnson Innovation Launches a New Company Incubation Model Located at the Janssen Research & Development Campus in Beerse, Belgium

    Beerse, Belgium
    March 16, 2016

    Johnson & Johnson Innovation Launches a New Company Incubation Model Located at the Janssen Research & Development Campus in Beerse, Belgium

  • Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc. Announce Agreement with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. to ...

    New Brunswick, N.J.
    January 7, 2016

    Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc. today announced an exclusive license agreement with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ), a Chinese domestic pharmaceutical company and subsidiary of Sino Biopharma, Ltd. focused on liver diseases, to develop, manufacture and commercialize, outside of China, undisclosed immune-modulating agents to treat human diseases, including curative treatment of chronic Hepatitis B virus (HBV) infection.

  • Johnson & Johnson Announces Completion of Novira Therapeutics, Inc. Acquisition

    New Brunswick, NJ
    December 4, 2015

    Johnson & Johnson (NYSE: JNJ) today announced the completion of the acquisition of Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing innovative therapies for curative treatment of chronic hepatitis B virus (HBV) infection. The transaction was originally announced on November 4, 2015. Financial terms of the transaction have not been disclosed.

     

Pages

Accelerators

Close
Neomed (Montreal)
7171 Frederick-Banting
Montreal, Quebec, CANADA H4S 1Z9
(514) 367 1212
mail@www.neomed.ca
www.neomed.ca
Your web browser is out of date. For the most optimal experience, please upgrade to the newest version of IE. Thank You.